Vorolanib is an oral, multikinase, dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with antiangiogenic and antineoplastic activities.
Molecular Weight:
439.4
Purity:
>99%
CAS Number:
[1013920-15-4]
Formula:
C23H26FN5O3
Target:
VEGFR/PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted